Gynesonics Names Taraneh G. Farazi Vice President, Clinical Affairs

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Gynesonics, a women's healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, today announced that veteran clinical affairs executive Taraneh G. Farazi, Ph.D., has been named Vice President, Clinical Affairs. Dr. Farazi reports directly to President and CEO Christopher M. Owens.

Suggested Articles

Europe-based venture capital company Sofinnova Partners has raised a meaty €333 million ($368 million) in an oversubscribed round.

The biotech aims to differentiate itself with technology that enables the insertion of large DNA sequences without the use of viral vectors. 

Medimmune’s Ronald Herbst, Ph.D., has followed a series of other AstraZeneca and its biologics arm staffers out the door.